Contain eating to a 12-hour window to contain weightPamela Mason describes research that suggests eating in a confined window of time may help to reduce weight gain.…
Could a probiotic pill cure diabetes?Recent news stories have suggested that a new probiotic pill could cure both type 1 and type 2 diabetes. However, much more research is required before these claims can be substantiated, writes Pamela Mason.…
US$2bn global innovation fund proposed to tackle antimicrobial resistance A worldwide innovation fund worth up to US$2bn could be set up to encourage the pharmaceutical industry to search for and develop new classes of antibiotics.…
Jean Lindenmann (1924–2015) Scientist Jean Lindenmann helped discover interferon, which is used to treat a variety of diseases.…
Drug candidate eCD4-Ig demonstrates durable protection against HIV infection A drug candidate known as “eCD4-Ig” — a fusion of CD4-Ig with a small CCR5-mimetic sulfopeptide — has efficiently neutralised 100% of a diverse panel of HIV-1, HIV-2 and simian immunodeficiency virus isolates.…
Viral cell entry holds clue to effective treatment of Ebola Scientists have identified an important pathway used by the Ebola virus to gain entry into cells that may lead to new therapeutic approaches.…
Reduction in antipsychotic use by dementia patients must continue, says CameronThe government wants to see a “significant” reduction in inappropriate prescribing of antipsychotic drugs to people with dementia in England in the next five years.…
Creatine does not slow progression in Parkinson’s disease, study finds Five years of creatine at a dose of 10mg/day does not slow disease progression in patients with early, stable Parkinson’s disease, a study published in JAMA shows.…
Researchers identify new anti-inflammatory compounds Two separate research groups have identified compounds that can inhibit components of the immune system that are involved in several inflammatory disorders.…
Researchers highlight possible Ebola drug target Scientists have identified an important virulence factor encoded by the Ebola virus, which they suggest could simplify drug development and regulatory approval.…